Champions Oncology (CSBR) Reports Q3 Loss of $0.11

March 16, 2017 4:04 PM EDT

Champions Oncology (NASDAQ: CSBR) reported Q3 EPS of ($0.11). Revenue for the quarter came in at $3.6 million, versus $0 reported last year.

For earnings history and earnings-related data on Champions Oncology (CSBR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings